Yield and clinical significance of genetic screening in elite and amateur athletes.
暂无分享,去创建一个
A. Pelliccia | G. Limongelli | E. Bossone | V. D’Argenio | M. V. Esposito | F. Salvatore | M. Penco | A. D’Andrea | P. Buono | S. Romano | M. Caiazza | C. Mazzaccara | G. Frisso | E. Monda | F. Paolo | Marcella Nunziato | Antonello D'Aponte | Federica Di Maggio | Paolo W Pica | Luca De Capua
[1] G. Limongelli,et al. Genetic analysis resolves differential diagnosis of a familial syndromic dilated cardiomyopathy: A new case of Alström syndrome , 2020, Molecular genetics & genomic medicine.
[2] A. Pressler,et al. Brief recommendations for participation in leisure time or competitive sports in athletes–patients with coronary artery disease: Summary of a Position Statement from the Sports Cardiology Section of the European Association of Preventive Cardiology (EAPC) , 2020, European journal of preventive cardiology.
[3] P. Elliott,et al. Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy. , 2020, International journal of cardiology.
[4] D. Corrado,et al. The Italian preparticipation evaluation programme: diagnostic yield, rate of disqualification and cost analysis , 2019, British Journal of Sports Medicine.
[5] M. Lafreniere-Roula,et al. Family screening for hypertrophic cardiomyopathy: Is it time to change practice guidelines? , 2019, European heart journal.
[6] A. Pressler,et al. Brief recommendations for participation in competitive sports of athletes with arterial hypertension: Summary of a Position Statement from the Sports Cardiology Section of the European Association of Preventive Cardiology (EAPC) , 2019, European journal of preventive cardiology.
[7] F. Pigozzi,et al. Electrocardiographic and echocardiographic evaluation of a large cohort of peri-pubertal soccer players during pre-participation screening , 2019, European journal of preventive cardiology.
[8] E. Behr,et al. Diagnostic Yield of Genetic Testing in Young Athletes With T-Wave Inversion , 2018, Circulation.
[9] H. Kwon,et al. DIFFERENT CONTRIBUTION OF SARCOMERE AND MITOCHONDRIA RELATED GENE MUTATIONS TO HYPERTROPHIC CARDIOMYOPATHY , 2018 .
[10] G. Lip,et al. Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE , 2017, European journal of preventive cardiology.
[11] C. Yancy,et al. Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. , 2016, Circulation.
[12] Andrea Mazzanti,et al. 2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2016, Revista espanola de cardiologia.
[13] B. Maron,et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology. , 2015, Journal of the American College of Cardiology.
[14] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[15] F. Rutten,et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). , 2014, European heart journal.
[16] C. Tracy,et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. , 2013, Heart rhythm.
[17] K. Siminovitch,et al. Sarcomere Protein Gene Mutations in Patients With Apical Hypertrophic Cardiomyopathy , 2011, Circulation. Cardiovascular genetics.
[18] F. Salvatore,et al. Efficacy of pharmacological treatment and genetic characterization in early diagnosed patients affected by long QT syndrome with impaired AV conduction. , 2011, International journal of cardiology.
[19] Wojciech Zareba,et al. Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, European heart journal.
[20] Barry J Maron,et al. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. , 2009, European heart journal.
[21] G. Limongelli,et al. A child cohort study from southern Italy enlarges the genetic spectrum of hypertrophic cardiomyopathy , 2009, Clinical genetics.
[22] D. Prior,et al. Athlete's heart: the potential for multimodality imaging to address the critical remaining questions. , 2009, JACC. Cardiovascular imaging.
[23] Maurizio Schiavon,et al. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death. , 2008, Journal of the American College of Cardiology.
[24] B. Maron,et al. Outcomes in athletes with marked ECG repolarization abnormalities. , 2008, The New England journal of medicine.
[25] Domenico de Rasmo,et al. A larger spectrum of intragenic short tandem repeats improves linkage analysis and localization of intragenic recombination detection in the dystrophin gene: an analysis of 93 families from southern Italy. , 2007, The Journal of molecular diagnostics : JMD.
[26] Barry J Maron,et al. The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. , 2006, Circulation.
[27] Maurizio Schiavon,et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. , 2006, JAMA.
[28] Maurizio Schiavon,et al. Does sports activity enhance the risk of sudden death in adolescents and young adults? , 2003, Journal of the American College of Cardiology.
[29] K. P. Carney,et al. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. , 2003, Journal of the American College of Cardiology.
[30] P. Kaufmann,et al. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy , 2001, Heart.
[31] B. Maron,et al. Prevalence of sudden cardiac death during competitive sports activities in Minnesota high school athletes. , 1998, Journal of the American College of Cardiology.
[32] D. Corrado,et al. Screening for hypertrophic cardiomyopathy in young athletes. , 1998, The New England journal of medicine.
[33] D. Atkins,et al. Cardiovascular preparticipation screening of competitive athletes. A statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. , 1996, Circulation.
[34] F O Mueller,et al. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. , 1996, JAMA.
[35] J E Smialek,et al. Sports-related and non-sports-related sudden cardiac death in young adults. , 1991, American heart journal.
[36] W. Roberts,et al. Sudden Death in Young Athletes , 1980, Circulation.
[37] G. Limongelli,et al. Genetic analysis in a family affected by sick sinus syndrome may reduce the sudden death risk in a young aspiring competitive athlete. , 2014, International journal of cardiology.
[38] G. Limongelli,et al. DNA sequence capture and next-generation sequencing for the molecular diagnosis of genetic cardiomyopathies. , 2014, The Journal of molecular diagnostics : JMD.